{"id":"NCT00620035","sponsor":"Organon and Co","briefTitle":"A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)","officialTitle":"An Open-Label, Non-Controlled Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03","primaryCompletion":"2010-10","completion":"2010-10","firstPosted":"2008-02-21","resultsPosted":"2011-10-31","lastUpdate":"2022-02-04"},"enrollment":301,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Contraception"],"interventions":[{"type":"DRUG","name":"Radiopaque Etonogestrel Implant","otherNames":["SCH 900415"]}],"arms":[{"label":"Radiopaque Etonogestrel Implant","type":"EXPERIMENTAL"}],"summary":"The primary purpose of this study is to evaluate the use of the next generation applicator and its instructions for proper insertion of the Radiopaque Implant. Secondary objectives include: evaluation of implant removal, evaluation of the overall contraceptive efficacy and safety of the Radiopaque Implant, assessment of x -ray visibility of the Radiopaque Implant, and to assess participant expectations and satisfaction with the Radiopaque Implant.","primaryOutcome":{"measure":"Percentage of Applicator Users Who Were Very Satisfied and Satisfied- User Satisfaction Questionnaire for Domain: Design & Technical Aspects","timeFrame":"Day 1","effectByArm":[{"arm":"Radiopaque Etonogestrel Implant","deltaMin":99.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["22939402"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":301},"commonTop":["Vaginal Haemorrhage","Headache","Metrorrhagia","Acne","Weight Increased"]}}